samedan logo
 
 
spacer
home > contact us
CONTACT US
Samedan Ltd. Pharmaceutical Publishing
16 Hampden Gurney Street,
London W1H 5AL, UK
Tel: +44 (0)20 7724 3456
Fax: +44 (0)20 7724 2632
E-mail: info@samedanltd.com  
     
Managing Director   Gulia Selby
     

Managing Editor

 

John White

 
Editorial Coordinators   Danielle Levett
Ed Swan
Editorial Assistant  

Jack Ratcliffe

     

Accounts and Finance

 

John Nicholas

     
Circulation Manager
& Digital Coordinator
  Catherine Makrandreou
Research & Circulation Assistant   Hannah Davies 
     
Senior Designer   Brendon Ward
     
EPC Sales Manager   Jonathan Smith
EPC Sales   Adam Mancey
EBR Sales Manager   Neil Clark
EBR Sales   Yvette Allen
PMPS Sales Manager   Lee Atkinson
PMPS Sales   Rakesh Makwana

ICT Sales Manager

  David Hirsh

IPT Sales

  Keith Martinez
Chris De Velera
     
     
     
     
spacer

Industry Events

3rd Annual Clinical Trial Management Systems (CTMS)

18-19 March 2010, Philadelphia, PA, US

Pharmaceutical and biotech companies are increasingly looking to clinical trial management systems (CTMS) to help streamline their clinical development operations. Building on a successful two-year history, this programme continues to serve as an excellent platform for industry discussion and collaboration among various CTMS stakeholders. This programme addresses the challenges of integrating CTMS systems both within the organisation across various other clinical systems as well as with external systems. Don’t miss this opportunity to hear in-depth industry case studies and learn from the challenges and successes of other companies.  
More info >>

News and Press Releases

BAC Extends Partnership with GE Healthcare to Launch Alpha-1 Antitrypsin Select

BAC BV, the leading provider of antibody-based affinity purification technology, has extended its collaboration with GE Healthcare with the addition of a new bioprocess affinity chromatography ligand to GE Healthcare’s range of custom designed media. The latest addition to the range is an affinity resin for the purification of alpha-1 antitrypsin (AAT) from blood plasma, recombinant cell culture or transgenic sources. The new resin has been developed as part of GE Healthcare’s Custom Designed Media (CDM) programme and provides a new solution for AAT purification in the biopharmaceutical industry.
More info >>

 
©2000-2007 Samedan Ltd.
About Us | Register | Login | Site Map | Terms and Conditions | Contact Us |
Add to favourites

Print this page

Send to a friend
Privacy statement